awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50120034-0D11019B-D81E-460C-AA87-E71682F9C49E
Q50120034-0D11019B-D81E-460C-AA87-E71682F9C49E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50120034-0D11019B-D81E-460C-AA87-E71682F9C49E
Anti-IgE and Biologic Approaches for the Treatment of Asthma.
P2860
Q50120034-0D11019B-D81E-460C-AA87-E71682F9C49E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50120034-0D11019B-D81E-460C-AA87-E71682F9C49E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9c004cfb9fbdc562af8f98c4392cfbe241b2dd5f
P2860
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials.